Literature DB >> 4101973

Demonstration of heavy and light chain antigenic determinants on the cell-bound receptor for antigen. Similarities between membrane-attached and humoral antibodies produced by the same cell.

C S Walters, H Wigzell.   

Abstract

High-rate antibody-forming cells and immunological memory cells can be selectively retained if filtered through a column coated with relevant antigen. This trapping can be blocked if the cells are incubated with an anti-immunoglobulin serum prior to column passage. A similar blocking is not observed when cells are treated with an anti-lymphocyte serum, thereby excluding the possibility that any antibodies combining with surface structures could cause this effect. By the use of antisera specific for heavy or light chain antigens, it was possible to locate such antigens in the antigen-binding receptor areas of immune cells. Criss-cross studies using antisera specific for gamma 1 or gamma 2a heavy chains showed that the membrane receptor has the same heavy chain as will be present in the eventual product of that cell, the humoral antibody.

Mesh:

Substances:

Year:  1970        PMID: 4101973      PMCID: PMC2180509          DOI: 10.1084/jem.132.6.1233

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Binding of radioiodinated bovine serum albumin to mouse spleen cells.

Authors:  D Naor; D Sulitzneau
Journal:  Nature       Date:  1967-05-13       Impact factor: 49.962

2.  Antibody production by isolated spleen cells: a study of the cluster and the plaque techniques.

Authors:  O B Zaalberg; V A van der Meul; M J van Twisk
Journal:  J Immunol       Date:  1968-02       Impact factor: 5.422

3.  Selective inhibition of the secondary response of primed cells by incubation with hapten.

Authors:  A M Cross; O Mäkelä
Journal:  Immunology       Date:  1968-09       Impact factor: 7.397

4.  Studies at the cellular level of the 19S immune response.

Authors:  H Wigzell; G Möller; B Andersson
Journal:  Acta Pathol Microbiol Scand       Date:  1966

5.  The role of cell number and source in adoptive immunity.

Authors:  O Mäkelä; N A Mitchison
Journal:  Immunology       Date:  1965-06       Impact factor: 7.397

6.  Studies on actively allergized cells. I. The cyto-dynamics and morphology of rosete-forming lymph node cells in mice and inhibition of rosette-formation with antibody to mouse immunoglobulins.

Authors:  I McConnell; A Munro; B W Gurner; R R Coombs
Journal:  Int Arch Allergy Appl Immunol       Date:  1969

7.  Cell separation on antigen-coated columns. Elimination of high rate antibody-forming cells and immunological memory cells.

Authors:  H Wigzell; B Andersson
Journal:  J Exp Med       Date:  1969-01-01       Impact factor: 14.307

8.  Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes.

Authors:  J F Miller; G F Mitchell
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

9.  Studies on rabbit lymphocytes in vitro. IV. Blast transformation of the lymphocytes from newborn rabbits induced by antiallotype serum to a paternal IgG allotype not present in the serum of the lymphocyte donors.

Authors:  S Sell; P G Gell
Journal:  J Exp Med       Date:  1965-11-01       Impact factor: 14.307

10.  Cellular differentiation of the immune system of mice. 3. Separate antigen-sensitive units for different types of anti-sheep immunocytes formed by marrow-thymus cell mixtures.

Authors:  G M Shearer; G Cudkowicz
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

View more
  33 in total

1.  Thymus-derived rat lymphocyte receptor for cell surface antigens is a nonserologically defined product of the major histocompatibility gene complex.

Authors:  H Wekerle; Z Eshhar; P Lonai; M Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

2.  In vitro production of IgE by lymphocytes from a patient with hyperimmunoglobulinaemia E, eosinophilia and increased lymphocytes carrying surface IgE.

Authors:  R Patterson; I M Suszko; C C Hsu; M Roberts; S H Oh
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

3.  Gene segments encoding membrane domains of the human immunoglobulin gamma 3 and alpha chains.

Authors:  M Bensmana; M P Lefranc
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

4.  A case of agammaglobulinemia characterized by a defect of B-lymphocyte-differentiation to plasma cells.

Authors:  U Hopf; J Knolle; M Bauchinger; J Freudenberg; K H Meyer zum Büschenfelde
Journal:  Klin Wochenschr       Date:  1974-06-01

5.  Lymphocytes with membrane-bound immunoglobulin (B-lymphocytes) in new-born babies.

Authors:  S S Fröland; J B Natvig
Journal:  Clin Exp Immunol       Date:  1972-08       Impact factor: 4.330

6.  Monoclonal IgM surface immunoglobulin on lymphocytes of aging NZB mice and its induction in young mice by RNA.

Authors:  N Bhoopalam; V Yakulis; P Heller
Journal:  Clin Exp Immunol       Date:  1974-02       Impact factor: 4.330

7.  Immune responses in vitro. IV. Suppression of primary M, G, and A plaque-forming cell responses in mouse spleen cell cultures by class-specific antibody to mouse immunoglobulins.

Authors:  C W Pierce; S M Solliday; R Asofsky
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

8.  Anit-immunoglobulins in multiple myeloma.

Authors:  N I Abdou; N L Abdou
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

9.  Receptors on immunocompetent cells. 3. Specificity and nature of receptors on dinitrophenylated guinea pig albumin- 125 I-binding cells of immunized guinea pigs.

Authors:  J M Davie; A S Rosenthal; W E Paul
Journal:  J Exp Med       Date:  1971-08-01       Impact factor: 14.307

10.  Suppression of immunoglobulin class synthesis in mice. I. Effects of treatment with antibody to -chain.

Authors:  A R Lawton; R Asofsky; M B Hylton; M D Cooper
Journal:  J Exp Med       Date:  1972-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.